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Abstract 
Background 
It is unclear whether Crohn’s disease (CD) is associated with skeletal disproportion in adulthood. 
Methods 
Height (Ht), sitting height (SHt) and leg length was studied in 44 children (C)  (M:22), 23 adults (M:10) with 
childhood-onset (CO-CD) and 26 adults (M:9) with adult-onset (AO) CD with a median (range) age of 13.7 
yrs (10, 17.3), 21.5 yrs (18, 32) and 31.0 yrs (18,40), respectively. 
Results 
Adults with CO-CD had a median Ht SDS of -0.9 (-2.3, 0.0) compared to 0.6 (-0.8,1.0) in those with AO-CD 
(p<0.05). Compare to normal, men, but not women, with CO-CD also had lower median SHt SDS at -1.1 
(2.5,-0.5) (p<0.05). The expected positive association that is normally found between leg length and SHt 
SDS was not evident in the adults with CO-CD.  
Conclusion 
Short stature in adults with childhood-onset CD is more pronounced in men and may be associated with poor 
spinal growth. 
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Introduction 
Crohn’s Disease (CD) often presents during early adolescence. Clinical presentation is commonly associated 
with short stature and, historically, delayed puberty. Adults with childhood-onset (CO) CD (CO-CD) are 
shorter than expected for their mid-parental height [1]. Although pubertal delay does not seem to be a major 
concern in children on contemporary therapy, affected children and adolescents with CD continue to remain 
shorter than the reference population [2] and exhibit suboptimal growth during puberty [3]. We performed a 
cross-sectional study of height and skeletal proportions in children with CD as well as adults with CO-CD 
and AO-CD to further explore the contribution of pubertal growth.  
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Patients & Methods  
Eligible participants were children less than 18 yrs old with CD attending the, Royal Hospital for Children, 
Glasgow and young adults between the age of 18 and 40 yr attending the Glasgow Royal Infirmary, 
Glasgow. The latter, were divided into two groups: CO-CD: onset <18 yr, AO-CD: disease onset ≥ 18 yr. 
Prepubertal onset of symptoms was defined using chronological age at onset of symptoms as <13 years for 
males and <11 years for females [2]. Patients with known endocrinopathies or other co-morbidities that may 
affect growth or skeletal development were excluded from recruitment. Clinical details were collected from 
case notes and face to face interview. Anthropometric data were obtained using standard protocols. Height 
(Ht) and Sitting Ht (SHt) were measured with a wall-mounted stadiometer with Leg length (LL) calculated 
as the difference between the Ht and SHt. Parental heights were measured for the children with CD and were 
self-reported by the adults with CD; 2 adults with CO-CD and 3 with AO-CD could not recall parental 
heights. 
 
All data were expressed as median (range) and analysed (Minitab 16, Coventry, UK). Ht, SHt and leg length 
(LL) were expressed as standard deviation scores (SDS) and short stature was defined as Ht SDS ≤ -2. A 
deviation from target/mid-parental Ht SDS was defined as the difference between the target and patient’s 
actual Ht SDS. One sample t-test was used to compare height measurements against the reference UK 
population data. Mann-Whitney U test was used for inter-group comparisons and Pearson correlation was 
used to assess associations between continuous variables. Statistical significance was set at a p<0.05. 
 
The study was approved by the West of Scotland Research Ethics Committee (10/S0701/66) and each 
participant provided written consent prior to study enrollment. 
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Results 
Participants Characteristics 
Participant characteristics are presented in Table 1. Of the 92 patients recruited, 44 were children with CD 
(M,22) , 26 were adults with AO-CD (M,9) and 23 were adults with CO-CD (M,10). Pre-pubertal onset of 
disease was noted in 29/44 (65.9%) children, and in 10/23 (43.4%) adults with CO-CD (Table 1). 
 
Height and skeletal proportions in children with CD 
There was no significant difference in Ht, SHt, and LL SDS between girls and boys (Table 1). Compared to 
the UK 1990 reference data, boys but not girls had a median Ht deficit of 0.63 SD (Table 1). Whilst both sex 
groups also had a lower SHt SDS, boys with CD also had a lower LL SDS (Table 1). There was a positive 
correlation between SHt and LL SDS in children with pre-pubertal (r=0.54; p=0.003) and pubertal (r=0.84; 
p<0.001) onset of CD (Figure 1).  The five children with greatest disproportion, either LL SDS ≤-2 or a SHt 
SDS≤-2, were amongst those with the lowest Ht SDS. The four (M,3) with low LL SDS but normal SHt  
SDS had pre-pubertal onset of CD and the one girl with low SHt SDS but normal LL SDS was diagnosed in 
mid-puberty.   
 
Final height and skeletal proportions in adults with adult and childhood-onset CD 
Median Ht SDS and SHt SDS in men with CO-CD was lower than that of AO-CD (Table 1). In addition, 
men with CO-CD also showed a larger deviation from target Ht. However, these men did not show a 
significant difference in LL SDS (Table 1). In women there was no significant difference in Ht, SHt, LL SDS 
and deviation from target Ht between participants with CO-CD or AO-CD (Table 1).  The positive 
association which was evident between SHt and LL SDS for adults with AO-CD (r=0.47; p=0.016) was not 
present in those with CO-CD (r=0.09; p=0.677) (Figure 1). Notably two patients each had LL SDS ≤-2 or 
low SHt SDS≤-2. These four represented those with the lowest Ht SDS within the entire group, all were 
adults with CO-CD (Figure 1). The two patients with low SHt SDS but normal LL SDS (patient A and B) 
were diagnosed in mid-puberty and the two with low LL SDS but normal SHt SDS (patient C and D) had 
pre-pubertal onset of CD. In the adults with CO-CD or AO-CD, there was no association of Ht or SHt SDS 
with the age at onset of disease, disease duration, Montreal classification of disease or the use of biologic 
therapy as a marker of disease severity.  
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 Female Male Female Male 
 C (n=22) C (n=22) CO-CD (n=13) AO-CD (n=17) CO-CD (n=10) AO-CD (n=9) 
 Median Range/% Median Range/% Median Range/% Median Range/% Median Range/% Median Range/% 
Age at diagnosis, (y) 10.9 6:15.5 11.1 2:14.2 14.0 10 : 17 24.0† 20 : 37 12.0 7 : 15 22.0† 19 : 27 
Age at recruitment, (y) 13.9 10:17 13.4 10:17.3 23.0 18 : 30 32.0† 22 : 40 20.0 18 : 32 30.0† 24 : 39 
Localisation:             
Ileal     1  5  3  2  
Colonic 4  4  3  2  2    
Ileocolonic 15  16  7  9  4  6  
Isolated upper     1      1  
Ileocolonic + upper 3  2  1    1    
Perianal 2      1      
Treatment:             
Surgery 0  0  5 38% 13 76% 6 67% 5 56% 
Biologics 2 9% 1 5% 5 38% 9 53% 7 78% 6 75% 
Thiopurines 12 55% 9 41% 5 38% 9 53% 1 11% 6 75% 
Methotrexate 6 27% 9 41% 4 31% 2 12% 2 22% 0 0% 
Aminosalicylates 7 32% 9 41% 6 46% 3 18% 2 22% 3 33% 
Oral steroids 2 9% 3 14% 4 31% 6 35% 0 0% 1 12% 
Anthropometry:             
Height SDS -0.1 -2.5:2.0 -0.2 -2.6:1.5 -0.4 -1.7 : 2.1 -0.1 -1.3 : 1.8 -0.9* -2.3 : 0.0 0.6†‡ -0.8 : 1.0 
Deviation from target height (SDS)§ -0.2 -2.5:1.3 -0.2 -2.4:2.4 0.1 -1.5 : 1.0 -0.2 -1.1 : 1.6 0.3 -0.5 : 1.5 -0.5† -1.5 : 1.0 
Sitting height SDS -0.4* -3.0:1.8 -0.5* -2.2:1.0 -0.6 -2.8 : 1.8 -0.7* -1.6 : 0.6 -1.1* -2.5 : -0.5 0.2†‡ -0.7 : 0.8 
Leg length SDS 0.0 -2.7:1.6 -0.3* -3.0:1.7 -0.1 -1.5 : 1.6 0.3 -1.6 : 1.8 -0.3 -3.1 : 1.4 0.4 -0.8 : 0.9 
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Discussion 
In contemporary cohorts, boys with CD are more likely to have an abnormality of pubertal growth despite 
satisfactory entry and progress through puberty [3], and are therefore, at risk of a lower final adult height. 
Poor growth, and an abnormality of the GH-IGF1 axis, are evident during periods of active disease and may 
be related to multiple factors including malnutrition and an elevation in pro-inflammatory cytokines [4]. In 
accordance with previous research [1], the current study suggests that short stature in childhood-onset CD 
may persist into adulthood. However, the current study also shows that the growth restriction is more likely 
in boys and may be linked more specifically to a reduction in spinal length. This finding of relative skeletal 
disproportion is further supported by the lack of association between LL and SHt in adults with CO-CD. 
Interestingly the four adults displaying the greatest disproportion had the lowest Ht SDS and all had CO-CD. 
A previous history of pubertal delay or abnormal pubertal growth provides a possible explanation for skeletal 
disproportion in adulthood [5] and may explain the greater height restriction as well as disproportion seen in 
boys with CD and men with CO-CD. There is also the possibility that the reduced sitting height seen in this 
study may be related to subclinical vertebral fractures or abnormal vertebral morphology, which is becoming 
increasingly recognised in young people with chronic inflammatory disease as well as those who require 
systemic glucocorticoids [6].  Prospective studies would require longitudinal assessment of puberty and 
radiological assessment of vertebral morphology. 
 
In summary, by showing that short stature in adults with CO-CD is more marked in boys and may be 
associated with skeletal disproportion, this study provides further mechanistic insight into the effect of 
childhood chronic disease on growth and skeletal development. 
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Table I: Demographics, disease characteristics and descriptors of height in children (C) and adults with 
childhood (CO-CD) and adulthood (AO-CD) onset Crohn’s disease. SDS – Standard deviation score; * 
p<0.05 compared with UK 1990; † p<0.05 ACO vs AAO for same gender; ‡ p<0.05 between genders for the 
same time of CD onset; § Difference between target (mid parental) and actual standing height SDS.  
 
 
Figure 1: Sitting Height SDS vs Leg Length SDS in Adults with Childhood (CO-CD) and adulthood (AO-
CD) onset Crohn’s Disease. Patient A: Male, HtSDS: -1.87, pubertal onset; Patient B: Female, HtSDS: -1.73, 
pubertal onset; Patient C: Male, HtSDS: -2.11, pre-pubertal onset; Patient D: Male, HtSDS:- -2.26, pre-
pubertal onset. SDS – Standard deviation score: Ht-height. 
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